Olmesartan Medoxomil and Hydrochlorothiazide

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product

Yes

Brand name base

Olmesartan Medoxomil and Hydrochlorothiazide

Listing expiration

2027-12-31

Active Ingredients#

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Related Records#

• All packages for product NDC 60290-026
• DailyMed label: Olmesartan Medoxomil and Hydrochlorothiazide
• FDA application 208847
• Company: Umedica Laboratories USA Inc.
• Search ingredient/name matches

Related UNII Ingredients#

Packages#

Related DailyMed Labels#